Sandu Pharmaceuticals (Small Cap - Potential Multibagger) Share Target 2025, 2026 To 2035
|
Sandu Pharmaceuticals Limited |
|||
|
Price: ₹52.63 (-0.27%) | ||
| 52 Week Low: ₹49.50 52 Week High: ₹72.49 |
|||
| Market Capital: 42.48 Crore (Smallcap) | |||
| -> | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Sandu Pharmaceuticals Share Price Target For 2025
- 1.1.1: Sandu Pharmaceuticals Share Price Target Table For 2025
- 1.1.2: Short-Term Technical Outlook
- 1.2: Sandu Pharmaceuticals Share Price Target For 2026
- 1.2.1: Sandu Pharmaceuticals Share Price Target Table For 2026
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Sandu Pharmaceuticals Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
- 3: Sandu Pharmaceuticals Financial Performance
- 3.0.1: Is Sandu Pharmaceuticals A Good Buy For Long Term?
Sandu Pharmaceuticals, a Small Cap company has delivered 242.9% returns in 5-year showing 4.9% quarterly revenue growth with 50.6% profit margin, making it a potential Multibagger.
To predict the Sandu Pharmaceuticals's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Sandu Pharmaceuticals Share Price Target For 2025
The line chart displays the monthly closing prices of Sandu Pharmaceuticals with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Sandu Pharmaceuticals shares in 2025, see the table below.
Sandu Pharmaceuticals Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 56.8 (+7.92%) | Price Action: 02 Dec 2024 Low |
| 2025 Target 2 | 56.16 (+6.7%) | Price Action: 08 Nov 2024 Low |
| 2025 Target 1 | 55.55 (+5.54%) | Price Action: 07 Oct 2024 Low |
| Current Price | 52.63 | Sandu Pharmaceuticals's share price as of 25 Feb 2025 |
| Stop Loss 1 | 51.12 (-2.87%) | Price Action: 25 Feb 2025 Low |
| Stop Loss 2 | 50.58 (-3.9%) | Price Action: 14 Feb 2025 Low |
| Stop Loss 3 | 50.0 (-5%) | Price Action: Jan 2016 High |
Short-Term Technical Outlook
Current Technical Position: Sandu Pharmaceuticals is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 25-day moving average at ₹52.93 serves as the nearest technical reference point.
Historical Returns: 3-month: -8.02% | 6-month: -10.89% | 1-year: -23.4%
Sandu Pharmaceuticals Share Price Target For 2026
The line chart displays the monthly closing prices of Sandu Pharmaceuticals with a black line. The green line shows three potential target prices for 2026, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Sandu Pharmaceuticals shares in 2026, see the table below.
Sandu Pharmaceuticals Share Price Target Table For 2026
| Level | Value | Analysis |
|---|---|---|
| 2026 Target 3 | 76.01 (+44.42%) | Fibonacci Extension Level 64.90% |
| 2026 Target 2 | 75.0 (+42.5%) | Price Action: 12 Feb 2024 High |
| 2026 Target 1 | 74.25 (+41.07%) | Price Action: 21 Feb 2024 High |
| Current Price | 52.63 | Sandu Pharmaceuticals's share price as of 25 Feb 2025 |
| Stop Loss 1 | 47.1 (-10.51%) | Price Action: Aug 2015 High |
| Stop Loss 2 | 46.63 (-11.41%) | Price Action: Chart |
| Stop Loss 3 | 45.0 (-14.5%) | Price Action: Aug 2021 Low |
Long-Term Technical Outlook
52-Week Range Analysis: Sandu Pharmaceuticals is currently trading near its 52-week low of ₹49.5, indicating potential value opportunity.
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: -23.4% | 3-year: -7.67% | 5-year: +242.87%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Sandu Pharmaceuticals Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹52.63 | ||
| 2025 | ₹60.09 | +14.17% | ₹60.99 |
| 2026 | ₹68.85 | +14.57% | ₹69.88 |
| 2027 | ₹67.73 | -1.62% | ₹68.75 |
| 2028 | ₹73.35 | +8.29% | ₹74.45 |
| 2029 | ₹77.49 | +5.64% | ₹78.65 |
| 2030 | ₹81.15 | +4.72% | ₹82.37 |
| 2031 | ₹87.25 | +7.51% | ₹88.56 |
| 2032 | ₹94.25 | +8.02% | ₹95.66 |
| 2033 | ₹95.40 | +1.22% | ₹96.83 |
| 2034 | ₹99.15 | +3.93% | ₹100.64 |
| 2035 | ₹111.34 | +12.29% | ₹113.01 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Sandu Pharmaceuticals Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 42.48 Crore | Market valuation of Sandu Pharmaceuticals's shares. |
| Revenue (TTM) | 65.34 Crore | Total revenue generated by Sandu Pharmaceuticals over the past twelve months. |
| Net Income (TTM) | +1.52 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +3.5% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +50.63% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+4.94% | Change in revenue compared to the previous quarter. |
Is Sandu Pharmaceuticals A Good Buy For Long Term?
Sandu Pharmaceuticals, a smallcap stock with 42.48 Crore market capitalization, exhibits a strong 50.63% profit margin and consistent growth, with a 4.94% revenue increase in the last quarter. While it has faced recent short-term setbacks, its long-term performance remains impressive, with substantial returns over 3, 5, and 12 months. Based on this data, Sandu Pharmaceuticals presents a compelling opportunity for long-term investors seeking stable growth and potential returns.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
